Research and Development

Showing 15 posts of 9603 posts found.

catherine_meaden

ABPI appoints Catherine Meaden as head of policy and public affairs

March 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS Direct, VBP

The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …
gsk_hq_logo

GSK collaborates with Dundee on neglected diseases

March 6, 2012 Research and Development, Sales and Marketing Africa, Dundee, GSK, Gates, Wellcome

GlaxoSmithKline has teamed up with Dundee University and the Wellcome Trust to develop new drugs for neglected diseases.  Healthcare charity …

Mundipharma appoints Paul Medeiros as head of corporate and business development

March 6, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Medeiros, Mundipharma

Mundipharma International has appointed Paul Medeiros as its new head of corporate and business development at its Cambridge, UK site.  …

Contract research news in brief

March 5, 2012 Research and Development CPR, Celeron/Ricerca, Certara, PRA, Quintiles

CPR opens first bioanalytical lab in Singapore, PRA wins an MS vaccine trial contract, plus M&A and alliance news from …
jlowinski

Former Bayer man becomes senior VP of Sanofi’s Asia region

March 5, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Asia, Bayer, Sanofi

Sanofi has appointed Jean-Luc Lowinski as its new senior vice president of the Asia region, effective from 1 May.  Jean-Luc …
RoActemra image

Roche’s RoActemra beats Humira in arthritis study

March 5, 2012 Research and Development, Sales and Marketing Humira, RA, RoActemra, Roche, arthritis

Roche’s rheumatoid arthritis drug RoActemra has beaten Abbott’s Humira in a head-to-head study. The Phase IV trial showed that RoActemra …

Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC

March 2, 2012 Research and Development

Catalent becomes #2 global clinical trial supply solutions provider

Chiltern welcomes Krista Stephenson to the global resourcing solutions team

March 2, 2012 Research and Development

 London, UK, February 28, 2012: Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Krista Stephenson has …

Good Pharmacovigilance Practice modules released by European Medicine Agency

March 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation.  …
Lilly scientists

Academic alliances to speed Lilly’s R&D

March 1, 2012 Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly

Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …

AstraZeneca announces several non-executive moves

March 1, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, appointments

AstraZeneca has announced that Leif Johansson is set to be elected as a non-executive director in April, with the intention …

Novartis appoints Brian McNamara to division head of OTC business

March 1, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC

Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …
Rare Disease Day

‘Rare Disease Day’ highlights need for research

February 29, 2012 Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire

 Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …

A wake-up call for big pharma

February 29, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma

The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …
Abbott image

Abbott buys into Galapagos’ RA candidate

February 29, 2012 Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …
The Gateway to Local Adoption Series

Latest content